Minireviews
Copyright ©The Author(s) 2021.
World J Hepatol. Oct 27, 2021; 13(10): 1289-1298
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1289
Table 1 Commonly accepted acute-on-chronic liver failure definitions

APASL
EASL
NASCELD
DefinitionAn acute hepatic insult manifesting as jaundice (serum bilirubin ≥ 5 mg/dL) and coagulopathy (INR ≥ 1.5) complicated within 4 wk by clinical ascites and/or encephalopathy in a patient with previously diagnosed or undiagnosed chronic liver disease/cirrhosis, and is associated with a high 28-d mortalityAn acute deterioration of pre-existing chronic liver disease usually related to a precipitating event and associated with increased mortality at 3 mo due to multisystem organ failureA syndrome characterized by acute deterioration of cirrhosis with two or more extrahepatic organ failure
Included patients Acute liver deterioration in patients with previously diagnosed or undiagnosed chronic liver disease including cirrhosis. Acute hepatic triggering factorsCirrhosis (compensated or decompensated)Cirrhosis (compensated or decompensated)
Renal failure is mandatoryTwo extrahepatic organ failure
Patients with an acute decompensation of cirrhosisPresentation not necessarily to be liver failure
Patients with prior decompensation of cirrhosisCan be repeated episodes of ACLF
Excluded patientsPatients with bacterial infectionsHCCHIV infection
Patients with cirrhosis who develop acute deterioration of their clinical status are considered to have acute decompensation but not ACLFHIV infectionDisseminated malignancies
Prior decompensation.Non-hepatic acute insults (such as sepsis)Receiving immunosuppressive treatments
Pediatric definitionFor children less than 3 years, modified HE assessment scale can be usedNoneNone
Clinical and/or radiological ascites can be used for defining ACLF in children
Table 2 Chronic liver failure–sequential organ failure assessment score
Organ/systems
0
1
2
3
4
Liver (bilirubin, mg/dL) < 1.2≥ 1.2 to < 2.0≥ 2.0 to < 6.0≥ 6.0 to < 12.0≥ 12.0
Kidney (creatinine, mg/dL) < 1.2≥ 1.2 to < 2.0≥ 2.0 to < 3.5≥ 3.5 to < 5.0(or RRT)≥ 5.0(or RRT)
Cerebral (HE grade)No HEIIIIIIIV
Coagulation (INR) < 1.1≥ 1.1 to < 1.25≥ 1.25 to < 1.5≥ 1.5 to < 2.5≥ 2.5 or platelet < 20 × 109 /L
Circulation (mean arterial pressure, mm Hg)≥ 70< 70Dopamine ≤ 5 or dobutamine or terlipressin(µg/kg/min)Dopamine > 5 or E ≤ 0.1 or NE ≤ 0.1(µg/kg/min)Dopamine > 15 or E > 0.1 or NE > 0.1(µg/kg/min)
Lungs
PaO/FiO2 > 400> 300 to ≤ 400> 200 to ≤ 300> 100 to ≤ 200≤ 100
or SpO2/FiO2 > 512> 357 to ≤ 512> 214 to ≤3 57< 89 to ≤ 214≤ 89
Table 3 Asian Pacific Association for the Study of the Liver Acute-on-Chronic Liver Failure score
Points
Total bilirubin (mg/dL)
HE grade
INR
Lactate (mmol/L)
Creatinine (mg/dL)
1< 150< 1.8< 1.5< 0.7
215-25I-II1.8-2.51.5-2.50.7-1.5
3> 25III-IV> 2.5> 2.5> 1.5
Table 4 Modified chronic liver failure–sequential organ failure assessment score
Organ/systems
0
1
2
3
4
Liver (bilirubin, mg/dL)< 1.2≥ 1.2 to < 2.0≥ 2.0 to < 6.0≥ 6.0 to < 12.0≥ 12.0
Kidney (creatinine, rise from baseline)< 1.5 ×1.5 to ≤ 2.0 ×> 2.0 to ≤ 3 ×> 3 ×Need for RRT
Cerebral (HE grade)0IIIIIIIV
Coagulation (INR)< 1.1≥ 1.1 to ≤ 1.25> 1.25 to < 1.5≥ 1.5 to ≤ 2.5> 2.5
Circulation (systolic BP)Normal for age< 5th centile for ageNE < 0.5 µg/kg/minNE > 0.5 µg/kg/minNE > 0.5 µg/kg/min and 2nd inotrope
Lungs
PaO/FiO2> 400> 300 to ≤ 400> 200 to ≤ 300> 100 to ≤ 200≤ 100
Table 5 Modified Asian Pacific Association for the Study of the Liver Acute-on-Chronic Liver Failure score
Points
Total bilirubin (mg/dL)
HE grade
INR
Lactate (mmol/L)
Creatinine (rise from baseline)
1< 150< 1.8< 1.5< 1.5 ×
215-25I-II1.8-2.51.5-2.51.5 to ≤ 3 ×
3> 25III-IV> 2.5> 2.5> 3 × or need RRT